Polymorphisms in some proinflammatory genes (TNF alpha and
beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease

J 2023

Polymorphisms in some proinflammatory genes (TNF alpha and beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease

SLONKOVÁ, Veronika, Anna VAŠKŮ a Vladimír VAŠKŮ

Základní údaje

Originální název

Polymorphisms in some proinflammatory genes (TNF alpha and beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease

Autoři

SLONKOVÁ, Veronika (203 Česká republika, domácí), Anna VAŠKŮ (203 Česká republika, garant, domácí) a Vladimír VAŠKŮ (203 Česká republika, domácí)

Vydání

JEADV - journal of the European Academy of Dermatology and Venereology, England, BLACKWELL PUBLISHING, 2023, 0926-9959

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30216 Dermatology and venereal diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 9.200 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130206

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1111/jdv.18770

UT WoS

000897650900001

Klíčová slova anglicky

polymorphisms; proinflammatory genes; severe chronic venous disease

Štítky

14110125, 14110518, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 26. 1. 2024 10:39, Mgr. Tereza Miškechová

Anotace

V originále

BackgroundChronic venous disease (CVD) is a common disorder of lower extremities. ObjectivesThe study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF alpha (-238 A/G; -308 A/G), TNF beta (NcoI), IL-1 beta (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3 ' TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD. MethodsFinally, 150 CVD patients and 227 control subjects were enrolled to the study.Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis. ResultsSignificant differences in genotype distribution/allelic frequencies in TNF beta gene, IL-1 beta gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6-men), ischaemic heart disease (TNF alpha and beta genes), diabetes mellitus (ADAM17-women, TNF beta-men), age of CVD onset (TNF alpha and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF alpha), varices surgery (TNF alpha), erysipelas development (ADAM17-men) and tumour development (TNF alpha). ConclusionStudying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.

Citovat

SLONKOVÁ, Veronika, Anna VAŠKŮ a Vladimír VAŠKŮ. Polymorphisms in some proinflammatory genes (TNF alpha and beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease. JEADV - journal of the European Academy of Dermatology and Venereology. England: BLACKWELL PUBLISHING, 2023, roč. 37, č. 3, s. 590-597. ISSN 0926-9959. Dostupné z: https://dx.doi.org/10.1111/jdv.18770.

@article{2248075,
   author = {Slonková, Veronika and Vašků, Anna and Vašků, Vladimír},
   article_location = {England},
   article_number = {3},
   doi = {http://dx.doi.org/10.1111/jdv.18770},
   keywords = {polymorphisms; proinflammatory genes; severe chronic venous disease},
   language = {eng},
   issn = {0926-9959},
   journal = {JEADV - journal of the European Academy of Dermatology and Venereology},
   title = {Polymorphisms in some proinflammatory genes (TNF alpha and beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease},
   url = {https://onlinelibrary.wiley.com/doi/10.1111/jdv.18770},
   volume = {37},
   year = {2023}
}

TY  - JOUR
ID  - 2248075
AU  - Slonková, Veronika - Vašků, Anna - Vašků, Vladimír
PY  - 2023
TI  - Polymorphisms in some proinflammatory genes (TNF alpha and beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease
JF  - JEADV - journal of the European Academy of Dermatology and Venereology
VL  - 37
IS  - 3
SP  - 590-597
EP  - 590-597
PB  - BLACKWELL PUBLISHING
SN  - 09269959
KW  - polymorphisms
KW  - proinflammatory genes
KW  - severe chronic venous disease
UR  - https://onlinelibrary.wiley.com/doi/10.1111/jdv.18770
N2  - BackgroundChronic venous disease (CVD) is a common disorder of lower extremities. ObjectivesThe study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF alpha (-238 A/G; -308 A/G), TNF beta (NcoI), IL-1 beta (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3 ' TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD. MethodsFinally, 150 CVD patients and 227 control subjects were enrolled to the study.Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis. ResultsSignificant differences in genotype distribution/allelic frequencies in TNF beta gene, IL-1 beta gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6-men), ischaemic heart disease (TNF alpha and beta genes), diabetes mellitus (ADAM17-women, TNF beta-men), age of CVD onset (TNF alpha and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF alpha), varices surgery (TNF alpha), erysipelas development (ADAM17-men) and tumour development (TNF alpha). ConclusionStudying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.
ER  -

SLONKOVÁ, Veronika, Anna VAŠKŮ a Vladimír VAŠKŮ. Polymorphisms in some proinflammatory genes (TNF alpha and beta, IL-1 beta, IL-6, ADAM17) in severe chronic venous disease. \textit{JEADV - journal of the European Academy of Dermatology and Venereology}. England: BLACKWELL PUBLISHING, 2023, roč.~37, č.~3, s.~590-597. ISSN~0926-9959. Dostupné z: https://dx.doi.org/10.1111/jdv.18770.

Podrobný výpis o publikaci